Overview and Scope
Heart blocks treatment devices are medical devices used to manage and correct disruptions in the electrical conduction system of the heart, specifically heart block. These devices help regulate the heart’s rhythm and ensure proper coordination between the heart’s chambers (atria and ventricles).
Sizing and Forecast
The heart blocks treatment devices market size has grown strongly in recent years. It will grow from $3.11 billion in 2023 to $3.3 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to growth in implantable cardioverter defibrillators (icds), evolution of cardiac resynchronization therapy (crt), miniaturization and leadless devices, clinical trials and evidence-based medicine, guidelines and recommendations, increasing incidence of cardiovascular diseases.
The heart blocks treatment devices market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to wireless connectivity and remote monitoring, expansion of wearable cardioverter defibrillators (wcds), personalized treatment algorithms, patient-centric design and comfort, increased adoption of mri-compatible device.. Major trends in the forecast period include growing integration of telemedicine platforms, remote programming and updates, ai-driven predictive maintenance, emphasis on user experience, expansion of home-based care..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/heart-blocks-treatment-devices-global-market-report
Segmentation & Regional Insights
The heart blocks treatment devices market covered in this report is segmented –
1) By Type: First-Degree Heart Block, Second-Degree Heart Block, Third-Degree Heart Block
2) By Product: Transcutaneous Pacing (TCP), Pacemaker, Mediation, Follow-Up Electrophysiology Study
3) By End-user: Hospital Testing, Home treatment, Clinics, Other End-Users
North America was the largest region in the heart blocks treatment devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart blocks treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12062&type=smp
Major Driver Impacting Market Growth
The rising prevalence of cardiovascular disease is expected to propel the growth of the heart blocks treatment devices market going forward. Cardiovascular diseases affect the heart and blood vessels and include conditions such as coronary artery disease, heart failure, and stroke. The rapidly increasing incidence of cardiovascular disease is mostly driven by the aging population, changes in lifestyle and diet, and increasing rates of obesity and diabetes, where heart blocks treatment devices can be used to treat cardiovascular disorders by addressing abnormalities or defects in the structures and blocks of the heart. For instance, in May 2023, according to an article by the Centers for Disease Control and Prevention, a US-based national public health agency, one person dies every 33 seconds in the United States from cardiovascular disease. About 695,000 people in the United States died from heart disease in 2021; that’™s 1 in every 5 deaths. Therefore, the rising prevalence of cardiovascular disease is driving the growth of the heart blocks treatment devices market.
Key Industry Players
Major companies operating in the heart blocks treatment devices market report are MicroPort Scientific Corporation, GE HealthCare, Abbott Laboratories, Medtronic PLC, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, Nihon Kohden Corporation, Lepu Medical Technology (Beijing) Co., Zoll Medical Corporation, LivaNova PLC, Abiomed Inc., Cardiac Dimensions, EBR Systems Inc., Endotronix Inc., Calon Cardio, CVRx Inc., BioVentrix Inc., CorWave SA, Leviticus Cardio, BiVACOR, Biotronik SE and CO KG, CorMatrix Cardiovascular, Shree Pacetronix Ltd., Jarvik Heart Inc., Osypka Medical GmbH.
The heart blocks treatment devices market report table of contents includes:
1. Executive Summary
2. Heart Blocks Treatment Devices Market Characteristics
3. Heart Blocks Treatment Devices Market Trends And Strategies
4. Heart Blocks Treatment Devices Market – Macro Economic Scenario
5. Global Heart Blocks Treatment Devices Market Size and Growth
.
.
.
31. Heart Blocks Treatment Devices Market Other Major And Innovative Companies
32. Global Heart Blocks Treatment Devices Market Competitive Benchmarking
33. Global Heart Blocks Treatment Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Heart Blocks Treatment Devices Market
35. Heart Blocks Treatment Devices Market Future Outlook and Potential Analysis
36.Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
